The global pain management devices market, valued at US$3491.0 million in 2023, stood at US$3,768.6 million in 2024 and is projected to advance at a resilient CAGR of 9.1% from 2024 to 2029, culminating in a forecasted valuation of US$5,835.8 million by the end of the period. The global upsurge in prevalence of chronic pain conditions, growth in geriatric populations, home care preference, favourable reimbursement scenario to improve the access of pain management devices, rising technological advancements and new product launches by key players are anticipated to propel the market growth during the forecast period.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=91418163
However, increasing product recalls and high procedural cost become barriers to growth of pain management devices among healthcare providers and patients. Additionally, stringent regulatory requirements and use of pain medication as first line treatment option pose a significant challenge to market players.
On the basis of applications, the pain management devices market is segmented into neuropathic pain, cancer pain, facial pain and migraine, musculoskeletal pain, and other applications (pregnancy/labor and menstrual pain, sports injuries, post-operative pain, and trauma pain). The neuropathic pain segment is estimated to witness the highest growth during the forecast period, primarily due to the high prevalence of diseases resulting in neuropathic pain.
On the basis of mode of purchase, the market is categorized into over-the-counter and prescription-based pain management device. The prescription-based devices segment is estimated to command a larger share, majorly due to the longer market presence of these devices with established safety and efficacy profiles and their long-term cost effectiveness.
Leading players in the pain management devices market are focusing on the strategies of new product launch and geographic expansion. These strategies help market players to strengthen their product portfolios, streamline their manufacturing capabilities, expand their distribution networks, and penetrate into high-growth markets.
